Pekin Hardy Strauss’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pekin Hardy Strauss’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$527K	Sell	4,125 -30	-0.7%	-$3.75K	0.06%	295
2025 Q4	$507K	Buy	4,155 +469	+13%	+$53.8K	0.05%	274
2025 Q3	$369K	Buy	3,686 +1,031	+39%	+$92.9K	0.04%	300
2025 Q2	$220K	Sell	2,655 -500	-16%	-$39.9K	0.03%	333
2025 Q1	$256K	Hold	3,155	–	–	0.03%	304
2024 Q4	$284K	Buy	3,155 +675	+27%	+$65.4K	0.04%	301
2024 Q3	$245K	Hold	2,480	–	–	0.03%	302
2024 Q2	$230K	Buy	2,480 +225	+10%	+$20.2K	0.03%	290
2024 Q1	$214K	Buy	+2,255	New	+$209K	0.03%	298
2023 Q2	–	Sell	-8,688	Closed	-$662K	–	336
2023 Q1	$662K	Sell	8,688 -5,840	-40%	-$485K	0.09%	180
2022 Q4	$1.21M	Sell	14,528 -2,295	-14%	-$186K	0.17%	126
2022 Q3	$1.33M	Sell	16,823 -4,725	-22%	-$398K	0.21%	113
2022 Q2	$1.6M	Buy	21,548 +16,880	+362%	+$1.27M	0.23%	108
2022 Q1	$420K	Buy	+4,668	New	+$431K	0.05%	240

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Pekin Hardy Strauss's XBI Position: Q1 2026 in Review

Pekin Hardy Strauss reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.72% in Q1 2026, selling an estimated $3.75K and leaving 4,125 shares worth $527K. The position accounts for 0.06% of the portfolio, ranked #295.

Pekin Hardy Strauss first reported a position in XBI in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.6M in Q2 2022. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Pekin Hardy Strauss held 4,125 shares of State Street SPDR S&P Biotech ETF worth $527K as of Q1 2026.
Pekin Hardy Strauss sold 30 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $3.75K.
State Street SPDR S&P Biotech ETF made up 0.06% of Pekin Hardy Strauss's portfolio in Q1 2026, its #295 holding.
Pekin Hardy Strauss first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 14 quarters since.
Pekin Hardy Strauss's State Street SPDR S&P Biotech ETF position peaked at $1.6M in Q2 2022.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Pekin Hardy Strauss's 13F filing for Q1 2026, filed 7 May 2026.